文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

1999-2015年美国儿童伤寒热:改善机会

Typhoid Fever in the US Pediatric Population, 1999-2015: Opportunities for Improvement.
PubMed 文献 · Clin Infect Dis · 2021-01-01

研究回顾1999-2015年美国CDC报告的儿童伤寒热病例及抗菌药物耐药数据。1992例儿童患者中81%有国际旅行史,81%住院,无死亡;83%符合疫苗接种条件但仅5%已知接种。61%分离株对氟喹诺酮类不敏感,22%为多重耐药,儿童耐药率高于成人。

要点

  • 儿童伤寒热多与国际旅行相关,住院率高但无死亡。
  • 符合疫苗接种条件的儿童中仅5%已知接种。
  • 氟喹诺酮不敏感和多重耐药在儿童中常见。

核心结论

  • 约95%符合当前疫苗条件的儿童旅行者未接种疫苗,且耐药感染常见。

研究设计与样本

  • 回顾性分析1999-2015年CDC报告的伤寒沙门菌感染及国家抗菌药物耐药监测系统药敏数据。

主要发现

  • 1992例儿童伤寒患者中1616例(81%)病前30天内有国际旅行史,1544/1906例(81%)住院,中位住院6天(范围0-50),无死亡。
  • 2003株测试分离株中1216株(61%)对氟喹诺酮不敏感,其中272株(22%)同时耐氨苄西林、氯霉素和复方磺胺甲噁唑(多重耐药);所有菌株对头孢曲松和阿奇霉素敏感。
  • 儿童多重耐药和氟喹诺酮不敏感率高于成人(16% vs 9%,P < .001;61% vs 54%,P < .001)。
  • 旅行相关病例氟喹诺酮不敏感率高于本土病例(70% vs 17%,P < .001)。

临床怎么用

  • 对赴伤寒流行区的儿童旅行者应评估疫苗接种指征并提高接种覆盖率。
  • 治疗儿童伤寒热时需考虑氟喹诺酮不敏感和多重耐药风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Typhoid fever in the United States is acquired primarily through international travel by unvaccinated travelers. There is currently no typhoid vaccine licensed in the United States for use in children <2 years. METHODS: We reviewed Salmonella enterica serotype Typhi infections reported to the Centers for Disease Control and Prevention (CDC) and antimicrobial-resistance data on Typhi isolates in CDC's National Antimicrobial Resistance Monitoring System from 1999 through 2015. RESULTS: 5131 cases of typhoid fever were diagnosed and 5004 Typhi isolates tested for antimicrobial susceptibility. Among 1992 pediatric typhoid fever patients, 1616 (81%) had traveled internationally within 30 days of illness onset, 1544 (81%) of 1906 were hospitalized (median duration, 6 days; range, 0-50), and none died. Forty percent (799) were <6 years old; 12% were <2 years old. Based on age and travel destination, 1435 (83%) of 1722 pediatric patients were vaccine-eligible; only 68 (5%) of 1361 were known to be vaccinated. Of 2003 isolates tested for antimicrobial susceptibility, 1216 (61%) were fluoroquinolone-nonsusceptible, of which 272 (22%) were also resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole (multidrug-resistant [MDR]). All were susceptible to ceftriaxone and azithromycin. MDR and fluoroquinolone-nonsusceptible isolates were more common in children than adults (16% vs 9%, P < .001, and 61% vs 54%, P < .001, respectively). Fluoroquinolone nonsusceptibility was more common among travel-associated than domestically acquired cases (70% vs 17%, P < .001). CONCLUSIONS: Approximately 95% of currently vaccine-eligible pediatric travelers were unvaccinated, and antimicrobial-resistant infections were common. New public health strategies are needed to improve coverage with currently licensed vaccines. Introduction of an effective pretravel typhoid vaccine for children <2 years could reduce disease burden and prevent drug-resistant infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. McAteer J, Derado G, Hughes M, et al. Typhoid Fever in the US Pediatric Population, 1999-2015: Opportunities for Improvement. Clin Infect Dis. 2021. PMID: 33247585. doi:10.1093/cid/ciaa914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。